Medication info

Trizel Injection (Metronidazole)

Prescription medication
Ingredient · strength
Metronidazole›500mg / 1 bottle
Manufacturer / importer
JW Pharmaceutical Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid contained in a colorless transparent glass vial or polypropylene container
Packaging
100 milliliters
Approval status
Active

MFDS item code 198400094 · Notified 1984.09.28 · Insurance code 644904072,644904076

Summary

Main use
Treatment of anaerobic bacterial infections, prevention of postoperative infections, and treatment of protozoal infections
Who uses it
Adults · Children
Adult dosage
(Tablets) Trichomoniasis: The usual adult dose is 250 mg of metronidazole orally twice daily for 10 days. Treatment of anaerobic bacterial infections: The usual adult dose is 500 mg per dose orally 3 ∼ 4 times daily. Do not exceed a maximum daily dose of 4 g; treatment is generally given for 7 ∼ 10 days. Postoperative prophylaxis of anaerobic bacterial infections: The usual initial adult dose is 1 g of this drug, followed by 250 mg per dose orally 3 times daily. Amebiasis: The usual adult dose is 500 ∼ 750 mg of this drug per dose orally 3 times daily for 5 ~ 10 days. (Injection) Administer the following dose slowly by intravenous injection at a rate of 25 mg (5 mL) per minute. Switch to oral therapy as soon as possible once the patient's condition improves. Prophylaxis of postoperative infections caused by anaerobic bacteria (use of this regimen is generally limited to 24 hours, and to a maximum of 48 hours).
Children's dosage
Treatment of anaerobic bacterial infections, adults and children 12 years of age and older: Administer 500 mg (100 mL) of metronidazole intravenously every 8 hours. When oral administration becomes possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injection treatment should not exceed 7 days, although treatment extension may be considered based on clinical and bacteriological assessment. Treatment of anaerobic bacterial infections, children under 12 years of age: Administer 3 times daily; the intravenous dose per administration is 7.5 mg (1.5 mL) of this drug per kg of body weight, and the oral dose per administration is also 7.5 mg of metronidazole per kg of body weight. Children under 8 weeks of age: Administer twice daily. Prophylaxis of postoperative infections caused by anaerobic bacteria, adults and children 12 years of age and older: Administer 500 mg (100 mL) of this drug intravenously every 8 hours immediately before, during, or after surgery. When oral administration becomes possible, switch to oral metronidazole 250 mg per dose 3 times daily. Prophylaxis of postoperative infections caused by anaerobic bacteria, children under 12 years of age: The preoperative intravenous dose is a single dose of 20~30 mg of this drug per kg of body weight. Premature infants: The preoperative intravenous dose is a single dose of 10mg of this drug per kg of body weight.

Ingredients

Manufacturer
JW Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of anaerobic bacterial infections, prevention of postoperative infections, and treatment of protozoal infections

  • Trichomoniasis
  • peritonitis
  • abdominal abscess
  • liver abscess
  • skin and soft tissue infections
  • endometritis
  • myometritis
  • ovarian abscess
  • bacterial sepsis
  • bone and joint infections
  • brain abscess
  • meningitis
View approved original text

This medication is used to treat infections caused by parasites such as trichomoniasis and amoebiasis. It also effectively treats various infections caused by anaerobic bacteria, including peritonitis, liver abscess, skin and soft tissue infections, and endometritis. This drug is helpful for central nervous system and lower respiratory tract infections, such as pneumonia, brain abscess, and bone and joint infections. It is particularly used to prevent anaerobic bacterial infections that may occur after surgery. Overall, it is an effective medication for improving various symptoms of anaerobic bacterial infections and parasitic infections.

Dosage and Administration

Adult dosage

(Tablets) Trichomoniasis: The usual adult dose is 250 mg of metronidazole orally twice daily for 10 days. Treatment of anaerobic bacterial infections: The usual adult dose is 500 mg per dose orally 3 ∼ 4 times daily. Do not exceed a maximum daily dose of 4 g; treatment is generally given for 7 ∼ 10 days. Postoperative prophylaxis of anaerobic bacterial infections: The usual initial adult dose is 1 g of this drug, followed by 250 mg per dose orally 3 times daily. Amebiasis: The usual adult dose is 500 ∼ 750 mg of this drug per dose orally 3 times daily for 5 ~ 10 days. (Injection) Administer the following dose slowly by intravenous injection at a rate of 25 mg (5 mL) per minute. Switch to oral therapy as soon as possible once the patient's condition improves. Prophylaxis of postoperative infections caused by anaerobic bacteria (use of this regimen is generally limited to 24 hours, and to a maximum of 48 hours).

Children's dosage

Treatment of anaerobic bacterial infections, adults and children 12 years of age and older: Administer 500 mg (100 mL) of metronidazole intravenously every 8 hours. When oral administration becomes possible, switch to oral metronidazole 500 mg 3 times daily. The total duration of injection treatment should not exceed 7 days, although treatment extension may be considered based on clinical and bacteriological assessment. Treatment of anaerobic bacterial infections, children under 12 years of age: Administer 3 times daily; the intravenous dose per administration is 7.5 mg (1.5 mL) of this drug per kg of body weight, and the oral dose per administration is also 7.5 mg of metronidazole per kg of body weight. Children under 8 weeks of age: Administer twice daily. Prophylaxis of postoperative infections caused by anaerobic bacteria, adults and children 12 years of age and older: Administer 500 mg (100 mL) of this drug intravenously every 8 hours immediately before, during, or after surgery. When oral administration becomes possible, switch to oral metronidazole 250 mg per dose 3 times daily. Prophylaxis of postoperative infections caused by anaerobic bacteria, children under 12 years of age: The preoperative intravenous dose is a single dose of 20~30 mg of this drug per kg of body weight. Premature infants: The preoperative intravenous dose is a single dose of 10mg of this drug per kg of body weight.

Precautions

This medication has been reported to cause tumor formation in rodent studies, so unnecessary use should be avoided. In patients with cocaine syndrome, administration of this medication may lead to serious hepatotoxicity or acute liver failure; therefore, liver function tests must be conducted, and hepatic function should be periodically monitored during and after treatment. If liver function deteriorates sharply, administration of this medication should be stopped immediately, and any signs of liver damage should be reported to a doctor without delay. This medication should not be used in patients who have an allergy to this drug or its components, have a history of blood disorders or neurological diseases, in pregnant women during the first three months of pregnancy, and in patients taking certain medications. Alcohol-dependent patients taking disulfiram should not be administered this medication, as it may cause psychotic reactions; alcohol consumption should be avoided during and for three days after treatment. Care should be taken when using this medication in patients with liver dysfunction, pregnant women beyond three months, patients with central nervous system infections, and patients requiring sodium restriction. This medication may cause various side effects in the gastrointestinal tract, blood, skin, and nervous system, so any unusual symptoms should be communicated to healthcare professionals immediately. In particular, if serious adverse reactions occur on the skin, administration should be stopped immediately, and care should be taken to avoid driving or operating machinery if confusion, hallucinations, convulsions, or visual disturbances occur. This medication may interact with anticoagulants such as warfarin, increasing the risk of bleeding; therefore, blood tests are necessary to adjust the dosage during treatment. Care should be taken when used in conjunction with drugs like lithium, phenytoin, phenobarbital, 5-FU, and cyclosporine due to the risk of changes in drug concentration or side effects. During pregnancy, this medication may affect the fetus, so it should not be administered to pregnant women within three months; breastfeeding should be discontinued as this drug's components can pass into breast milk. In case of overdose, there is no specific antidote, so general treatment should be administered, and it should not be mixed with other antibiotics for injection or administered via routes other than intravenous drip. Any leftover medication should not be used, and this medication should be managed as a stock solution that requires no compounding.

Side effects

Elevated serum amylase, upper abdominal pain, nausea, vomiting, diarrhea, oral mucositis, taste disorders, loss of appetite, reversible pancreatitis, leukopenia, neutropenia, agranulocytosis, thrombocytopenia, rash, itching, flushing, hives, fever, angioedema, anaphylactic shock, pustular rash, erythema multiforme, aseptic meningitis, headache, seizures, dizziness, ataxia, syncope, tonic-clonic seizure, peripheral sensory neuropathy, encephalopathy, confusion, subacute cerebellar syndrome, ataxia, speech disorder, gait disorder, eye twitching, tremor, venous thrombosis, mental disorder, depressed mood, diplopia, myopia, optic neuropathy, elevated liver enzyme levels, cholestasis, hepatitis, jaundice, skin and mucous membrane syndrome, toxic epidermal necrolysis, eosinophilia, drug reaction, acute generalized exanthematous pustulosis, vesicular dermatitis, fixed drug eruption, hearing impairment, hearing loss, tinnitus, fever, drowsiness, glossitis, lip dryness, hematuria, arthralgia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air. It is recommended to store it in a cool place, away from direct sunlight, at room temperature between 1 and 30 degrees Celsius. Additionally, it should be kept in a safe place inaccessible to children or animals.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid contained in a colorless transparent glass vial or polypropylene container

Package unit

100 milliliters

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.